Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries.

about

Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries.

Item

http://www.wikidata.org/entity/Q50044569

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Management of Hodgkin lymphoma ...... from five European countries.

@en

Management of Hodgkin lymphoma ...... from five European countries.

@nl

type

Item

label

Management of Hodgkin lymphoma ...... from five European countries.

@en

Management of Hodgkin lymphoma ...... from five European countries.

@nl

prefLabel

Management of Hodgkin lymphoma ...... from five European countries.

@en

Management of Hodgkin lymphoma ...... from five European countries.

@nl

P1476

Management of Hodgkin lymphoma ...... from five European countries.

@en

P2093

Antonio Rueda

http://www.w3.org/2001/XMLSchema#string

Bastian von Tresckow

http://www.w3.org/2001/XMLSchema#string

Gilles Salles

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

Hodgkin lymphoma, version 2.2015.

ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.

Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 t

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.

P304

2113-2120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1421762

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Graham P Collins

Francesco Zaja

P577

2018-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29334819

http://www.w3.org/2001/XMLSchema#string